Harmony Farms

With some calls for additional data or formatting changes, testimony in a hearing on legislation to set up a WSLCB data dashboard was largely supportive.

Legislation to alter a planned transfer of cannabis lab accreditation authority was broadly praised by the sponsor, agency leaders, and cannabis sector stakeholders. 

By the end of Tuesday, Representatives tasked with oversight of the adult-use cannabis market were scheduled to have heard five bills and considered moving two in the first days of the week.

Lab representatives and other stakeholders pointed out discrepancies, redundancies, and costs related to proposed lab quality standards leading staff to ultimately choose to rework the rules.

Staff received more input on how draft agency request bills on contract growing for patients and advertising changes might potentially impact patients, businesses, and the cannabis market.

WSLCB leaders introduced two concepts for 2024 request legislation, one for medical patients to contract with licensees; another to revise limits around cannabis retail advertising.

Researchers ran through various efforts to regulate cannabis concentrates which had been supported by some stakeholders before taking questions on how to influence legislators and the public.

Committee members heard testimony in favor, opposed, and ‘other’ while seeking suggestions on THC levels for hemp products after the Senate decided any amount of THC was too much. 

Within its fiscal committee, testimony on a cannabinoid regulation bill championed by WSLCB was divided, there were THC threshold concerns, but also claims the bill helped cannabis tax revenue.

Feedback on a bill to legalize out-of-state cannabis license ownership was divided: some companies anticipated benefits while others viewed the move as only helping larger entities.